Imperva (IMPV) Tops Q1 EPS by 12c; Guides FY15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- S&P 500, Nasdaq set for lower open as chip weakness weighs
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil rises over 1% as Iran threat puts Red Sea route at risk
- Citi sees Google, Meta and Amazon capex spending at over $800 billion in 2027
- UnitedHealth shares surge on strong earnings beat and guidance
Needham & Company Raises PT Sharply as Imperva (IMPV) Raises Guidance
May 8, 2015 6:59 AM EDTNeedham & Company reiterates their Buy rating on Imperva, Inc. (NYSE: IMPV), and raised the price target to $67 (from $48), after a strong, and well above consensuses, March quarter. IMPV reported a revenue of $44.8m (well above $40.5m consensus), and a loss of $0.26 per share was smaller than the $0.38 loss expected. IMPV raised their June quarter consensus to $47-$49m and (0.20) to (0.24), which is... More
Oppenheimer Raises PT After Imperva's (IMPV) Strong 1Q Showing
May 8, 2015 6:38 AM EDTOppenheimer reiterates their Outperform rating on Imperva, Inc. (NYSE: IMPV), and raised their price target to $58 (from $55), after a strong 1Q15.IMPV reported revenue up 42% YoY to $44.8M, which bested Oppenheimer estimates of $40.5M. IMPV also reported a loss per share of $0.26, better than estimated... More
